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1091-207 Primary and Secondary Prevention Implantable 
Cardioverter Defibrillator Patients Have Similar 
Proportions of Ventricular Tachyarrhythmia Detections 
and Equivalent Risk for Spurious Therapies: Results 
From PainFREE Rx II
Michael O. Sweeney, Mark S. Wathen, Ismaile Abdalla, Paul J. DeGroot, Mary F. 
Otterness, Alice J. Stark, Brigham and Women's Hospital, Boston, MA, Vanderbilt 
University Medical Center, Nashville, TN
Background: ICDs reduce mortality in primary (Prim) and secondary (Second) preven-
tion pts. However, "overtreatment" in Prim remains a concern, potentially at the cost of
spurious therapies for inappropriate ventricular detections due to SVT. We compared
appropriate and inappropriate ventricular detections in 584 pts (Prim = 202, 35%; Sec-
ond = 382, 65%) in PainFREE Rx II, a prospective randomized study of antitachycardia
pacing (ATP) or shocks for fast VT (FVT).
Methods: All ICDs were identically programmed at implant with 3 zones (VT < 188 bpm;
FVT = 188-250 bpm; VF > 250 bpm) but with either ATP or shock for FVT. An expert
panel adjudicated all detected episodes that had stored electrograms. GEE methods
were used to account for multiple episodes/pt and are reflected in percentages and p-val-
ues.
Results: Prim pts were significantly older, had lower EF and more CAD. Gender, b-block-
ers, antiarrhythmic drugs, and length of follow-up were similar between groups. During
follow-up of 11 ± 3 months, 1670 ventricular episodes were detected as: 738 VT, 391
FVT, 123 VF, and 418 SVT. The distribution of VT, FVT, and VF was similar between Prim
vs Second (VT: 99/276 [44%] vs 639/976 [46%], p=0.77; FVT: 138/276 [41%] vs 253/976
[39%], p=0.71; VF: 39/276 [15%] vs 84/976 [14%], p=0.86). Proportion of pts with >1
appropriate episode was similar in Prim vs Second (21% vs 27%, p=0.13). But among
pts with appropriate episodes, the median number of episodes per pt was significantly
lower for Prim than for Second (1 vs 3, p=.05). The proportion of pts with >1 inappropri-
ate episode was similar in Prim vs Second (16% vs 15%, p=0.81), and the proportion of
inappropriate episodes was greater in Prim but the difference was not significant (Prim,
121/397 [42%] vs Second, 297/1273 [34%], p=.21).
Conclusions: Similar proportions of Prim and Second pts have appropriate detections
for potentially life-threatening VT, FVT and VF but with less frequency in Prim. Inappropri-
ate detections account for more than one-third of all ventricular episodes in both groups.
Prim pts do not appear to be "overtreated" compared to Second pts and are at equivalent
risk for spurious therapies.
1091-208 Syncope in Implantable Cardioverter Defibrillator 
Patients: Predictors and Outcomes
Dalia Giedrimiene, Danette Guertin, Jeffrey Kluger, Hartford Hospital, Hartford, CT
Background: The ability of ICD to terminate ventricular tachyarrhythmias and to reduce
the rate of sudden death is well established. However, syncope may still occur and
impact quality of life and survival. The purpose of this study was to identify predictors of
syncope development in patients with ICD therapy using clinical and electrophysiological
characteristics.
Methods: We retrospectively reviewed a prospectively collected ICD database of 309 pts
with primary ICD implants at our institution between 1999 and 2002. 139 pts developed
ICD therapy during a mean follow-up period of 21.7±11.6 months. There were 108 males
and 31 females (av. age 65.2±11.8) with the following presenting arrhythmias: 56 (40.3%)
- sustained monomorphic ventricular tachycardia (MVT); 19 (13.7%) - ventricular fibrilla-
tion (VF), 44 (31.7%) - non-sustained ventricular tachycardia (NSVT); and 20 (14.4%) -
syncope. Groups of pts with syncope during ICD therapy and without syncope were com-
pared for clinical and electrophysiological variables and outcomes.
Results: 
Conclusions: Syncope is not uncommon at the time of ICD device therapy and occurs in
older patients with more depressed EF. Patients with syncope during ICD therapy are
more likely to have syncope at presentation. ICD related proarrhythmia occurs more fre-
quently, and the rate of ICD treated VT is faster in patients with syncope. The total mor-
tality also appears to be greater in ICD patients who experience syncope at the time of
device therapy.
1091-209 Cardiac Resynchronization Therapy Results in a Lower 
Arrhythmia Burden
Philippine Kiès, Sander G. Molhoek, Jeroen J. Bax, Lieselot van Erven, Marianne 
Bootsma, Katja Zeppenfeld, Ernst E. van der Wall, Martin J. Schalij, Leiden University 
Medical Center, Leiden, The Netherlands
Introduction: Patients at high-risk for ventricular tachycardias due to dilated cardiomyop-
athy who are treated with an Implantable Cardioverter Defibrillator (ICD) may progress to
severe heart failure. These patients may become eligible for cardiac resynchronisation
therapy (CRT) by means of biventricular pacing. We hypothesized that CRT can affect
the number of arrhythmic events. The aim of this study was to evaluate whether long-
term CRT influences the number of ventricular tachycardias in patients with dilated cardi-
omyopathy implanted with a CRT-ICD.
Methods: Seventeen ICD patients (13 men, age 60 ±11yrs, 59% ischemic heart dis-
ease) were studied. The NYHA class was 3.2±0.4, with a left ventricular ejection fraction
(LVEF) of 19.5±7 %. Each patient underwent an upgrade to a CRT-ICD device. The num-
ber of ICD therapies was obtained by analyzing the ICD printouts, which were acquired
every 3 months during the year before and the year after upgrading. Clinical data were
obtained during outpatient clinic visits and by chart-review.
Results: At 12-month follow-up after CRT treatment NYHA class improved to 2.2±0.5
(p<0.01) and LVEF improved to 23.5±9% (p<0.01). During the year before implantation of
the ICD-CRT device, 8 of 17 patients (47%) experienced 242 VT episodes. After implan-
tation of the CRT device 3 of 17 patients (18%) experienced 19 VT episodes (p =0.01).
None of the patients experienced an episode of ventricular fibrillation during the evalu-
ated period.
Conclusion: Upgrade to CRT-ICD improves heart failure status and LVEF, and reduces
the number of ventricular arrhythmias.
1091-210 The World Trade Center Attack: Increased Frequency of 
Defibrillator Shocks for Ventricular Arrhythmias in 
Patients Living Remotely From New York City
Omer L. Shedd, Jonathan S. Steinberg, Aysha Arshad, Jane Harvill, Anne Curtis, 
University of Florida, Gainesville, FL
Background: A two-fold increase in the frequency of implantable cardioverter defibrilla-
tor (ICD) shocks for potentially life-threatening ventricular arrhythmias was reported
among patients living in New York City in the month following the attack on the World
Trade Center (WTC) compared to the month before the tragedy. However, whether this
effect also occurred in patients living geologically distant from New York is unknown. We
sought to determine whether the attack on 9/11/01 had an effect on the occurrence of
ventricular arrhythmias among patients with ICDs living in Florida at that time.
Methods:This was an observational study in which the population consisted of 132 con-
secutive ICD patients who presented to the University of Florida and the Veterans Affairs
(VA) Hospital in Gainesville, Florida for routine ICD follow-up around the time of the WTC
attack. The occurrence of ventricular tachyarrhythmias that triggered ICD therapy in the
30 days before and after 9/11/01 constituted our primary end point.
Results: In the 30 days following the WTC attack a total of 14 patients (11%) had ventric-
ular tachyarrhythmias, compared to only 5 patients (3.5%) in the preceding 30 days. This
represents a 3.14-fold increase in risk. Patients with ventricular arrhythmias both before
and after 9/11/01 demonstrated a rate increased of 2.38 events per patient (95%
CI=0.05-0.40 p=0.00042)
Conclusions: The frequency of ventricular arrhythmias requiring ICD treatment
increased by more than 3-fold among patients living in Florida around the time of the
WTC attack. Moreover, patients with ventricular arrhythmias in the 30 days before and
after 9/11/01 experienced at least a doubling of the rate of arrhythmia. These finding sug-
gest that stress related arrhythmogenesis due to the WTC tragedy was not restricted to
the geographical location of the attack. Additionally, the attacks likely caused more signif-
icant levels of morbidity because they affected a larger number of patients than previ-
ously estimated. A major national tragedy may cause a widespread increase risk of
potentially life-threatening ventricular arrhythmias.
1091-211 Heart Rate Dynamics Before the Onset of Ventricular 
Tachyarrhythmias: Results of the Cardioverter 
Defibrillator Registry MARITA
Alexander Schirdewan, Udo Meyerfeldt, Niels Wessel, Hans J. Bondke, Peter Schreiber, 
Rainer Sadowski, Wolfram Kamke, Michael Wiedemann, Franz-Volhard-Hospital, 
Charite, Helios-Klinikum, Humboldt-University, Berlin, Germany
Background: Implantable Cardioverter-Defibrillators (ICDs) are the standard therapy in
patients with ventricular tachyarrhythmia (VTA) and provide a unique opportunity to ana-
lyze beat-to-beat (RR)-interval variability (HRV) before the onset of such life-theatening
event. The aim of this study was to assess the ability of a Multivariate Analysis of RR-
Intervals to predict these VTA (MARITA Trial).
METHODS: One hundred eighty-six patients (153 men, mean age 61.0±10.4) with an
implanted ICD (Biotronik, 9000 RR-intervals capacity) for recurrent VTA provided 257
heart rate recordings before a VTA (94 patients) and 645 series during control conditions:
recordings at follow-up date without VTA. From these time series we analysed 107 VTA
and 422 control recordings which were in sinus rhythm, more than one hour long and had
Variables Syncope n=30 No Syncope n=109 P-value 
Age 65.3±10.8 63.6±12.5 0.463
Gender M/F 23/7 85/24
Lowest EF % 23.1±15.6 30.7±16.8 0.05*
Inducible VT (%) 15 (50%) 77(70.6%) 0.05*
Ischemic Heart Disease 21(70%) 74(67.9%) 0.83
ICD treated VT cycle (ms) 237.5±50.1 309.3±32.55 0.001*
More than 1 shock of ICD 5(16.7%) 29(26.6%) 0.22
ICD proarrhythmia % 5 (16.7%) 7 (6.4%) 0.05*
Syncope at presentation % 18 (60%) 42 (38.5%) 0.042*
Mortality % 11 (36.7%) 19(17.4%) 0.05*
Mortality in less than 6 months 2/11(18.2%) 6/19 (39.6%) 0.42
* p < 0.05
